Roles of IL-4 and IL-12 in the Development of Lupus in NZB/W F1 Mice

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1466-1472

  Nakajima, Atsuo ^a,b   Hirose, Sachiko ^a   Yagita, Hideo ^a   Okumura, Ko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 4; RECOMBINANT PROTEIN;

ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BIOSYNTHESIS; FEMALE; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; METABOLISM; MOUSE; NEW ZEALAND BLACK MOUSE; PHYSIOLOGY; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-12; INTERLEUKIN-4; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; MICE, INBRED NZB; RECOMBINANT PROTEINS; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0031065236     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
2. Klinman, D. M., and A. D. Steinberg. 1995. Inquiry into murine and human lupus. Immunol. Rev. 144:157.
3. Foster, M. H., B. Cizmen, and M. P. Madaio. 1993. Biology of disease: nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanism of immune deposition, genetic origins. Lab. Invest. 69:494.
4. - T helper cell lines that express the γδ T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87:7020.
5. Datta, S. K., H. Patel., and D. Berry. 1987. Induction of a cationic shift in IgG anti-DNA autoantibodies. J. Exp. Med. 165:1252.
6. Sekigawa, I., Y. Ishida, S. Hirose, H. Sato, and T. Shirai. 1986. Cellular basis of in vitro anti-DNA antibody production: evidence for dependence of IgG-class anti-DNA antibody synthesis in the (NZBXNZW) F1 hybrid. J. Immunol. 136: 1247.
7. Wofsy, D., and W. E. Seaman. 1985. Successful treatment of amoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378.
8. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
9. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
10. +T cells. Annu. Rev. Immunol. 12:635.
11. +T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34.
12. Finkelman, F. D. 1995. Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease. J. Exp. Med. 182:279.
13. +T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
14. Hsieh, C.-S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukin 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
15. +T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
16. Leonard, J. P., K. E. Waldburger, and S. J. Goldmann. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
17. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
18. Trembleau, S., T. Germann, M. K. Gately, and L. Adorini. 1995. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16:383.
19. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
20. Nakajima, A., M. Azuma, S. Kodera, S. Nuriya, A. Terashi, S. Hirose, T. Shirai, H. Yagita, and K. Okumura. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur. J. Immunol. 25:3060.
21. + T cell subsets defined by expression of CD45RC and NTA260 antigens and age-associated polarization in murine lupus. Int. Immunol. 7:1115.
22. Al-janadi, M., S. Al-balla, A. Al-dalaan, and S. Raziuddin. 1993. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic disease. J. Clin. Immunol. 13:58.
23. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J.-C. Brouet, D. Alarcon-Segovia, P. Galanaud, and D. Emilie. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839.
24. Jacob, C. O., P. H. van der Meide, and H. O. McDevitt. 1987. In vivo treatment of (NZB × NZW)F1 lupus-like nephritis with monoclonal antibody to γ-interferon. J. Exp. Med. 166:798.
25. Ryffel, B., B. D. Car, H. Gunn, D. Roman, P. Hiestand, and M. J. Mihatsch. 1994. Interleukin-6 exacerbates glomerulonephritis in (NZB/NZW)F1 mice. Am. J. Pathol. 144:927.
26. Finck, B. K., B. Chan, and D. Wofsy. 1994. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J. Clin. Invest. 94:585.
27. Ishida, H., T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon, and M. Howard. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305.
28. Hirose, S., R. Nagasawa, I. Sekikawa, M. Hamaoki, Y. Ishida, H. Sato, and T. Shirai. 1983. Enhancing effect of H-2-linked NZW gene(s) on the autoimmune trails of (NZB/NZW)F1 mice. J. Exp. Med. 158:228.
29. Hirose, S., K. Kinoshita, S. Nozawa, H. Nishimura, and T. Shirai. 1990. Effect of major histocompatibility complex on autoimmune disease of N-2-congenic New Zealand mice. Int. Immunol. 2:1091.
30. Hirano, T., H. Miyajima, N. Watanabe, H. Yagita, S. Enomoto, S. Furusawa, Z. Ovary, T. Honjo, and K. Okumura. 1988. An improved method for the detection of IgE antibody of defined specificity by ELISA using rat monoclonal anti-IgE antibody. Int. Arch. Allergy Appl. Immunol. 85:4517.
31. Azuma, M., T. Hirano, H. Miyajima, N. Watanabe, H. Yagita, S. Enomoto, S. Furusawa, Z. Ovary, T. Kinashi, T. Honjo, and K. Okumura. 1987. Regulation of murine IgE production in SLA/9 and nude mice. J. Immunol. 139:2538.
32. Snapper, C. M., and W. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
33. Stevens, T. L., A. Bossie, V. M. Saders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255.
34. Finkelman, F. D., and J. Holmes. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
35. Germann, T., M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, L. Kolbe, E. Kolsch, F. J. Podlaski, M. K. Gately, and E. Rude. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:823.
36. Buchanan, J. M., L. A. Vogel, V. H. Van Cleave, and D. W. Metzger. 1995. Interleukin 12 alters the isotype-restricted antibody response of mice to hen egg white lysozyme. Int. Immunol. 7:1519.
37. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.
38. Maliszewski, C. R., K. Grabstein, W. C. Fanslow, R. Armitage, M. K. Spriggs, and T. A. Sato. 1993. Recombinant CD40 ligands stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur. J. Immunol. 23:1044.
39. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
40. Murphy, E. E., G. Terres, S. T. Macatonia, C.-S. Hsieh, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223.
41. Jacob, C. O., and H. O. McDevitt. 1988. Tumor necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature 331:356.
42. Gordon, C., G. E. Ranges, J. S. Greenspan, and D. Wofsy. 1989. Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice. Clin. Immunol. Immunopathol. 52:421.
43. Takahashi, S., M. Nose, J. Sasaki, T. Yamamoto, and M. Kyogoku. 1991. IgG3 production in MRL/Ipr mice in responsible for development of lupus nephritis. J. Immunol. 147:515.
44. Lemoine, R., T. Berney, T. Shibata, T. Fulpius, Y. Gyotoku, H. Shimada, S. Sawada, and S. Izui. 1992. Induction of wire-loop lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 41:65.
45. Itoh, J., M. Nose, S. Takahashi, M. Ono, S. Terasaki, E. Kondoh, and M. Kyogoku. 1993. Induction of different types of glomerulonephritis by monoclonal antibodies derived from an MRL/Ipr mouse. Am. J. Pathol. 143:1436.
46. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97: 61597.
47. Roberts, J. L., R. J. Wyatt, M. M. Schwartz, and E. J. Lewis. 1983. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis. Clin. Immunol. Immunopathol. 29:223.
48. Capra, J. D., and H. G. Kunkel. 1970. Aggregation of 73 proteins: relevance to the hyperviscosity syndrome. J. Clin. Invest. 49:610.
49. Haward, M. G., P. F. Kohler, W. D. Terry, and E. C. Franklin. 1968. Human monoclonal γG-cryoglobulins with anti-γ-globulin. J. Clin. Invest. 47:1968.
50. Abdelmoula, M., F. Spertini, T. Shibata, Y. Gyotoku, S. Luzuy, P.-H. Lambert, and S. Izui. 1989. IgG3 is the major source of cryoglobulins in mice. J. Immunol. 143:526.
51. Armitage, R. J., B. M. Macduff, M. K. Spriggs, and W. C. Fanslow. 1993. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150:3671.
52. Von der Weide, T., M. Kopt, G. Kohler, and J. Langhorne. 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 24:2285.
53. Noben-Trauth, N., P. Kropt, and I. Muller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science. 271:987.
54. Finkelman, F. D., I. M. Katona, J. F. Urban, Jr, J. Holmes, J. Ohara, A. S. Tung, J. G. Sample, and W. E. Paul. 1988. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:2335.
55. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
56. Hagiwara, E., M. F. Gourley, S. Lee, and D. M. Klinman. 1996. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum. 39:379-385.